Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

AI-assisted peRsonalized heart-on-chIp as advanced diagnostic Tool for clinical significance assessMent of Inherited cArdiomyopathies

Objective

Inherited cardiomyopathies (iCMPs) are a major causeInherited cardiomyopathies (iCMPs) are a major cause of heart disease and account for a significant percentage of deaths in young patients. While recent advances in next-generation sequencing have enabled testing of a large number of genes related to iCMPs, the rate of identification of pathogenic variants is still below 50%. On the other hand, this unprecedented sequencing power has led to an exponential increase in detecting novel unclassified genetic variants (VUS), for which pathogenicity has not been confirmed. VUS uncertainty of diagnosis poses important problems in clinical evaluations, therapeutic decisions and risk-assessment both for patient and family members.
The AI-RITMIA Consortium proposes a breakthrough innovation to establish a conclusive link between specific VUSs and CMP
clinical phenotypes, yielding to the development of an unprecedented technological platform: a radically new AI-guided patient-specific heart-on-chip diagnostic tool (AI-RITMIA) will be able to interface for the first time three currently diverging sectors: patient specific in vitro modelling, in silico and artificial intelligence (AI) based data handling and clinical evaluation. AI-RITMIA will be the first clinical grade personalized in vitro-in silico platform enabling faster and unbiased correlations of clinical outcomes with functional in vitro profiling for VUS-carrying patients, returning a pathogenicity score directly to the clinicians to unlock informed diagnosis and therapeutic decisions. The achievement of such innovation will leverage on enabling technologies and resources uniquely available in the Consortium, which brings together excellences from the three interfacing worlds: 1) in vitro models based on OoC and microsensors @POLIMI, @BIOMIMX, @NMI and patient-specific iPSCs @ICH; 2) the largest EU cohort of well characterized CMP patients @COCHIN, and 3) clinical grade AI-based data handling interfaces @TUM, @ADVICE.

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) HORIZON-EIC-2025-PATHFINDEROPEN

See all projects funded under this call

Coordinator

POLITECNICO DI MILANO
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 682 500,00
Address
PIAZZA LEONARDO DA VINCI 32
20133 Milano
Italy

See on map

Region
Nord-Ovest Lombardia Milano
Activity type
Higher or Secondary Education Establishments
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 682 500,00

Participants (6)

My booklet 0 0